Tissue | Expression Dynamics | Abbreviation |
Colorectum (GSE201348) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Becker/TLK2_pca_on_diff_genes.png) | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Chen/TLK2_pca_on_diff_genes.png) | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Endometrium | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Endometrium/TLK2_pca_on_diff_genes.png) | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/TLK2_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/TLK2_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/TLK2_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/TLK2_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:20000591 | Colorectum | SER | negative regulation of ubiquitin-dependent protein catabolic process | 17/2897 | 48/18723 | 5.46e-04 | 7.63e-03 | 17 |
GO:00181051 | Colorectum | SER | peptidyl-serine phosphorylation | 66/2897 | 315/18723 | 5.47e-03 | 4.06e-02 | 66 |
GO:00421762 | Colorectum | MSS | regulation of protein catabolic process | 145/3467 | 391/18723 | 2.03e-18 | 1.17e-15 | 145 |
GO:19033622 | Colorectum | MSS | regulation of cellular protein catabolic process | 99/3467 | 255/18723 | 1.90e-14 | 5.37e-12 | 99 |
GO:00104982 | Colorectum | MSS | proteasomal protein catabolic process | 157/3467 | 490/18723 | 2.39e-13 | 5.25e-11 | 157 |
GO:00313302 | Colorectum | MSS | negative regulation of cellular catabolic process | 96/3467 | 262/18723 | 2.67e-12 | 4.63e-10 | 96 |
GO:00098952 | Colorectum | MSS | negative regulation of catabolic process | 110/3467 | 320/18723 | 7.88e-12 | 1.20e-09 | 110 |
GO:19030502 | Colorectum | MSS | regulation of proteolysis involved in cellular protein catabolic process | 82/3467 | 221/18723 | 4.97e-11 | 5.64e-09 | 82 |
GO:00431612 | Colorectum | MSS | proteasome-mediated ubiquitin-dependent protein catabolic process | 127/3467 | 412/18723 | 7.70e-10 | 6.32e-08 | 127 |
GO:20000582 | Colorectum | MSS | regulation of ubiquitin-dependent protein catabolic process | 61/3467 | 164/18723 | 1.28e-08 | 7.61e-07 | 61 |
GO:00611362 | Colorectum | MSS | regulation of proteasomal protein catabolic process | 67/3467 | 187/18723 | 1.45e-08 | 8.47e-07 | 67 |
GO:19033632 | Colorectum | MSS | negative regulation of cellular protein catabolic process | 34/3467 | 75/18723 | 8.96e-08 | 4.44e-06 | 34 |
GO:00421772 | Colorectum | MSS | negative regulation of protein catabolic process | 47/3467 | 121/18723 | 1.28e-07 | 6.01e-06 | 47 |
GO:00105062 | Colorectum | MSS | regulation of autophagy | 95/3467 | 317/18723 | 4.36e-07 | 1.71e-05 | 95 |
GO:00324342 | Colorectum | MSS | regulation of proteasomal ubiquitin-dependent protein catabolic process | 49/3467 | 134/18723 | 6.02e-07 | 2.26e-05 | 49 |
GO:20000592 | Colorectum | MSS | negative regulation of ubiquitin-dependent protein catabolic process | 22/3467 | 48/18723 | 1.33e-05 | 3.07e-04 | 22 |
GO:00458612 | Colorectum | MSS | negative regulation of proteolysis | 97/3467 | 351/18723 | 1.57e-05 | 3.54e-04 | 97 |
GO:19030512 | Colorectum | MSS | negative regulation of proteolysis involved in cellular protein catabolic process | 26/3467 | 64/18723 | 3.19e-05 | 6.30e-04 | 26 |
GO:00324352 | Colorectum | MSS | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 17/3467 | 35/18723 | 5.07e-05 | 9.12e-04 | 17 |
GO:00063252 | Colorectum | MSS | chromatin organization | 107/3467 | 409/18723 | 7.22e-05 | 1.21e-03 | 107 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TLK2 | SNV | Missense_Mutation | novel | c.1820N>C | p.Gly607Ala | p.G607A | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
TLK2 | SNV | Missense_Mutation | | c.1219N>C | p.Glu407Gln | p.E407Q | Q86UE8 | protein_coding | deleterious(0.01) | benign(0.371) | TCGA-A2-A0CX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
TLK2 | SNV | Missense_Mutation | | c.1730N>T | p.Ala577Val | p.A577V | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.926) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TLK2 | SNV | Missense_Mutation | | c.1658A>G | p.Asp553Gly | p.D553G | Q86UE8 | protein_coding | deleterious(0) | possibly_damaging(0.685) | TCGA-D8-A1XC-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
TLK2 | SNV | Missense_Mutation | novel | c.93N>G | p.Asn31Lys | p.N31K | Q86UE8 | protein_coding | deleterious_low_confidence(0.02) | benign(0.007) | TCGA-PE-A5DC-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
TLK2 | SNV | Missense_Mutation | novel | c.1703G>A | p.Arg568Gln | p.R568Q | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.909) | TCGA-UL-AAZ6-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | herceptin | SD |
TLK2 | SNV | Missense_Mutation | rs200158456 | c.127N>A | p.Gly43Arg | p.G43R | Q86UE8 | protein_coding | deleterious_low_confidence(0) | probably_damaging(1) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TLK2 | SNV | Missense_Mutation | novel | c.1864G>T | p.Asp622Tyr | p.D622Y | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.928) | TCGA-C5-A8XI-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | SD |
TLK2 | SNV | Missense_Mutation | | c.857G>C | p.Arg286Thr | p.R286T | Q86UE8 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-JX-A3Q0-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Unknown | Unknown | SD |
TLK2 | SNV | Missense_Mutation | | c.1801N>C | p.Val601Leu | p.V601L | Q86UE8 | protein_coding | tolerated(0.24) | probably_damaging(0.981) | TCGA-Q1-A73O-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |